Protecting Life Sciences IP in China: Innovation, Legal Change, and Business Strategy


As China’s economy continues to surge and move up the product cycle, the country is on track to become a global leader in life sciences innovation and manufacturing. Foreign firms, which hold a 30 percent share of the local market, are rapidly expanding their biotech investments in China – in manufacturing, joint ventures, and R&D — yet they continue to face many challenges.

One of the greatest remains intellectual property (IP) protection, as counterfeiting, piracy, and other IP violations remain daunting issues. It is not only foreign firms that are concerned over IP in China; the vast majority of IP violation claims filed in China are made by Chinese firms, and there is a growing domestic constituency for strong, transparent, and consistent IP protection. As China's own hi-tech sectors grow, so too will calls for stronger IP law and enforcement.

Please join us for a half-day conference that will feature more than a dozen of the world’s leading specialists in intellectual property rights and the life sciences industries. The conference will both survey the rapidly evolving state of IP protection in China and consider practical steps and strategies that firms can take to protect IP and to address cases of IP infringement. Achieving the right mix of legal, strategic, and operational considerations is difficult, but the conference's legal and business experts from both China and the U.S. will show how it can be done.

MCLE credit (1) available

Keynotes: Dr. Wei Huacheng, Chairman of the Board, Beijing Pharmaceutical Group Co., Ltd., and Dr. Oliver Lutze, Head of Intellectual Property Rights, Bayer (China) Ltd.
Panelists: Greg Scott, ChinaBio LLC | Alex Wu, Crown Bio Science Inc. | Karen Wong, Wilson Sonsini Goodrich & Rosati | James Zhu, Jun He Law Offices | Jimmy Zhang, Synergenics, LLC/BayHelix | Barbara Rudolph, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP | Janet Xiao, Morrison & Foerster LLP/CABS | Charles Comey, Morrison & Foerster LLP | Robert Garland, New Enterprise Associates | Jonathan Norris, Silicon Valley Bank | Michael Zielenziger, UC Berkeley Institute of International Studies | Douglas Crawford, QB3, UC San Francisco

Sponsors: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Morrison & Foerster LLP; Silicon Valley Bank; and Wilson Sonsini Goodrich & Rosati

Media Sponsor: San Francisco Business Times

Promotional co-sponsors: Asian Pacific Islander American Public Affairs Association (APAPA), Bay Area Council, BayHelix, BioE2E, California-Asia Business Council, ChinaBio, Chinese American Biopharmaceutical Association (CABS), ORIENTED.COM, UC Berkeley Boalt School of Law International and Executive Legal Education (IELE), UC Hastings School of Law, UC San Francisco QB3, US-Asia Technology Management Center, U.S. Export Assistance Center (USEAC) of Silicon Valley, Zoomedia, Inc.

Event Details

Mon 07 Nov 2011
12:30 PM - 5:30 PM

Genetech Auditorium, UCSF Mission Bay, 600 16th Street, San Francisco, CA

Buy Tickets
Students $50. Asia Society/Co-sponsor Members $75. Non-members $100.
Add to Calendar 20111107T203000 20111108T013000 UTC Asia Society: Protecting Life Sciences IP in China: Innovation, Legal Change, and Business Strategy Genetech Auditorium, UCSF Mission Bay, 600 16th Street, San Francisco, CA